Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
| Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
|---|---|
| Data(s) |
01/11/2013
01/11/2013
2012
|
| Resumo |
Federal University of Sao Paulo Federal University of Paraiba CAPES |
| Identificador |
CLINICS, SAO PAULO, v. 67, n. 3, pp. 283-287, AUG, 2012 1807-5932 http://www.producao.usp.br/handle/BDPI/37244 10.6061/clinics/2012(03)14 |
| Idioma(s) |
eng |
| Publicador |
HOSPITAL CLINICAS, UNIV SAO PAULO SAO PAULO |
| Relação |
CLINICS |
| Direitos |
openAccess Copyright HOSPITAL CLINICAS, UNIV SAO PAULO |
| Palavras-Chave | #TYPE-2 DIABETES-MELLITUS #SIGNALING PATHWAYS #GLUCOSE-TOLERANCE #NONOBESE WOMEN #METFORMIN #PCOS #MANIFESTATIONS #HORMONE #DISEASE #OBESE #MEDICINE, GENERAL & INTERNAL |
| Tipo |
article original article publishedVersion |
